The Making of a Healthcare Giant: Manipal’s Journey Across India

Date:

Share post:

In 1991, Dr Ramdas Pai- son of T.M.A Pai, founder of Manipal town set out to do something. India desperately needed: build serious multi speciality healthcare infrastructure for people who had none. Manipal hospitals was born from that ambition and it would go on to become one of the country’s most influential healthcare networks.

The early days weren’t easy. Specialised medical infrastructure was scarce and steep import taxes made building world class facilities an uphill battle. But Manipal had one powerful advantage. Its reputation as an educational institution. That credibility helped reverse the brain drain, drawing top physicians and clinicians back from across the globe to practice on Indian soil.

Through the 1990s, Manipal expanded steadily across South India setting up secondary and tertiary care Centre. By the early 2000s, growth accelerated, capacity crossed 2000 beds, and the group made a pivotal strategic shift from organic growth to acquisition led expansion. Backed by private equity players like Kotak and TPG, Manipal made its move into north India transforming from a regional player into National force.

Today the results speak for themselves. Manipal‘s acquisition strategy has significantly widened its bed capacity and geographic footprint . In 2024, its research wing secures multiple patents for AI driven diagnostic tools, sharpening its clinical edge. The group has also been honoured with several golden peacock national awards, recognising its consistency in healthcare delivery.

Yet with rapid growth comes a real challenge, maintaining quality across every new facility, protecting both reputation and regulatory standing.

Manipal’s journey proves that healthcare expansion isn’t just about scale. It’s about scaling without ever compromising care.

Written by: Srabanti Bhattacharjee

Graphics by: Sowmyodeep Roy

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...